Pulmonary Embolism in Patients With Covid-19 Pneumonia: The Utility of D-dimer.
作者信息
Rodriguez-Sevilla Juan José, Rodó-Pin Anna, Espallargas Irene, Villar-García Judit, Molina Lluis, Pérez Terán Purificación, Vázquez Sanchez Antonia, Masclans Joan Ramón, Jiménez Carmen, Millan Segovia Raúl, Zuccarino Flavio, Salar Antonio, Rodriguez-Chiaradía Diego A
机构信息
Department of Hematology, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
Pulmonology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Pompeu Fabra (UPF), CIBERES, (ISCiii), Barcelona, Spain.
出版信息
Arch Bronconeumol (Engl Ed). 2020 Nov;56(11):758-759. doi: 10.1016/j.arbres.2020.06.013. Epub 2020 Jul 15.
Abstract
摘要
相似文献
1
Pulmonary Embolism in Patients With Covid-19 Pneumonia: The Utility of D-dimer.新冠肺炎患者的肺栓塞：D-二聚体的作用
Arch Bronconeumol (Engl Ed). 2020 Nov;56(11):758-759. doi: 10.1016/j.arbres.2020.06.013. Epub 2020 Jul 15.
2
Venous thromboembolism and COVID-19.静脉血栓栓塞与2019冠状病毒病
Respir Med Res. 2020 Nov;78:100759. doi: 10.1016/j.resmer.2020.100759. Epub 2020 Apr 28.
3
Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan.武汉市 COVID-19 相关肺炎患者急性肺栓塞的特征。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620936772. doi: 10.1177/1076029620936772.
4
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).新型冠状病毒肺炎与止血：来自意大利血栓形成与止血协会（SISET）的立场文件。
Blood Transfus. 2020 May;18(3):167-169. doi: 10.2450/2020.0083-20. Epub 2020 Apr 8.
5
Pulmonary embolism in hospitalised patients with COVID-19.COVID-19 住院患者中的肺栓塞。
Thromb Res. 2020 Nov;195:95-99. doi: 10.1016/j.thromres.2020.07.025. Epub 2020 Jul 10.
6
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.COVID-19：凝血功能障碍、血栓形成风险和抗凝治疗的理由。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620938149. doi: 10.1177/1076029620938149.
7
Coagulation abnormalities and thrombosis in patients with COVID-19.新型冠状病毒肺炎患者的凝血异常与血栓形成
Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.
8
Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.2019冠状病毒病、血栓形成前因素与静脉血栓栓塞症
Semin Thromb Hemost. 2020 Oct;46(7):772-776. doi: 10.1055/s-0040-1710337. Epub 2020 May 11.
9
Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to d-Dimer Levels.新型冠状病毒肺炎患者急性肺栓塞的CT血管造影表现及其与D-二聚体水平的关系
Radiology. 2020 Sep;296(3):E189-E191. doi: 10.1148/radiol.2020201561. Epub 2020 Apr 23.
10
Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients.D-二聚体升高和未抗凝与重症 COVID-19 患者的 PE 相关。
Eur Respir J. 2020 Oct 22;56(4). doi: 10.1183/13993003.01811-2020. Print 2020 Oct.
引用本文的文献
1
Coagulopathy and thromboembolic events a pathogenic mechanism of COVID-19 associated with mortality: An updated review.凝血功能障碍和血栓栓塞事件是 COVID-19 相关死亡率的发病机制：最新综述。
J Clin Lab Anal. 2023 Jun;37(11-12):e24941. doi: 10.1002/jcla.24941. Epub 2023 Jul 11.
2
Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.COVID-19 感染对既往呼吸道疾病的短期和长期影响。
Arch Bronconeumol. 2022 Apr;58 Suppl 1:39-50. doi: 10.1016/j.arbres.2022.03.011. Epub 2022 Apr 15.
3
Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.人恢复期血浆可保护K18-hACE2小鼠免受严重呼吸道疾病的侵害。
J Gen Virol. 2021 May;102(5). doi: 10.1099/jgv.0.001599.
4
Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression.D-二聚体在 COVID-19 中的诊断价值：荟萃分析和荟萃回归。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211010976. doi: 10.1177/10760296211010976.
5
COVID-19 and venous thromboembolism: Known and unknown for imaging decisions.新型冠状病毒肺炎与静脉血栓栓塞症：影像诊断的已知与未知
World J Radiol. 2021 Mar 28;13(3):64-74. doi: 10.4329/wjr.v13.i3.64.
本文引用的文献
1
Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study.新型冠状病毒肺炎患者疾病严重程度与炎症相关参数的相关性分析：一项回顾性研究。
BMC Infect Dis. 2020 Dec 21;20(1):963. doi: 10.1186/s12879-020-05681-5.
2
Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action.新型冠状病毒肺炎患者的血栓栓塞风险和抗凝治疗：新出现的证据和行动呼吁。
Br J Haematol. 2020 Jun;189(5):846-847. doi: 10.1111/bjh.16727. Epub 2020 May 4.
3
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
4
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).2019年欧洲心脏病学会（ESC）与欧洲呼吸学会（ERS）合作制定的急性肺栓塞诊断和管理指南。
Eur Heart J. 2020 Jan 21;41(4):543-603. doi: 10.1093/eurheartj/ehz405.
5
D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial.D-二聚体作为急性住院患者静脉血栓栓塞症的预测因子：随机对照 MAGELLAN 试验的亚组分析。
J Thromb Haemost. 2014 Apr;12(4):479-87. doi: 10.1111/jth.12515.
6
Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.急性病且近期活动能力下降的医学患者中延长时间的静脉血栓栓塞症预防：一项随机试验。
Ann Intern Med. 2010 Jul 6;153(1):8-18. doi: 10.7326/0003-4819-153-1-201007060-00004.
7
Safety of excluding acute pulmonary embolism based on an unlikely clinical probability by the Wells rule and normal D-dimer concentration: a meta-analysis.基于 Wells 评分和正常 D-二聚体浓度排除急性肺栓塞的低临床可能性的安全性：一项荟萃分析。
Thromb Res. 2010 Apr;125(4):e123-7. doi: 10.1016/j.thromres.2009.11.009. Epub 2009 Nov 26.
8
D-Dimer for venous thromboembolism diagnosis: 20 years later.用于静脉血栓栓塞症诊断的D-二聚体：20年后
J Thromb Haemost. 2008 Jul;6(7):1059-71. doi: 10.1111/j.1538-7836.2008.02981.x. Epub 2008 Jul 1.
9
10
Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome.登革出血热的凝血异常：对167例越南登革休克综合征患儿的系列研究
Clin Infect Dis. 2002 Aug 1;35(3):277-85. doi: 10.1086/341410. Epub 2002 Jul 11.
Zotero 插件